Allied Healthcare Products
This article was originally published in The Gray Sheet
Executive Summary
Completes acquisition of Toledo, Ohio-based B&F Medical Products for 640,000 shares of Allied common stock and an estimated $11.7 mil. in cash, "subject to certain adjustments," Allied announces. On Sept. 2, the last trading day before the announcement, Allied stock closed at $16 per share, making the total deal worth about $22 mil. B&F Medical manufactures plastic disposable medical products primarily for the home health care market. The company had net sales of approximately $23 mil. for the fiscal year ended April 30, with income from operations of $2.5 mil. St. Louis-based Allied, a manufacturer of medical gas equipment and respiratory therapy products, had net sales of $74.1 mil. for its fiscal year ending June 30 and net income of $7.3 mil
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.